Biomarkers of gluten sensitivity in patients with non-affective psychosis: A meta-analysis

  title={Biomarkers of gluten sensitivity in patients with non-affective psychosis: A meta-analysis},
  author={Laura Lachance and Kwame McKenzie},
  journal={Schizophrenia Research},

Figures and Tables from this paper

A review on the relationship between gluten and schizophrenia: Is gluten the cause?
There were no consistent results in the clinical, immunological, microbiological, and epidemiological studies that investigated the relationship between schizophrenia and celiac disease, and a need for a larger scale study to confirm the presence of this suggested correlation.
The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia
The association between intestinal permeability and inflammation in the schizophrenic patients only was noted and the risk for developing schizophrenia was 4.35 (95% confidence interval) for AGA IgA and 3.39 for positive AGA IgG.
Gluten Psychosis: Confirmation of a New Clinical Entity
It is confirmed that psychosis may be a manifestation of non-celiac gluten sensitivity, and may also involve children; the diagnosis is difficult with many cases remaining undiagnosed.
Gluten related illnesses and severe mental disorders: a comprehensive review
Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review.
All of the included studies found that a GFD is well tolerated and can be adhered to by patients with schizophrenia, and further research is required to examine the biomarkers of gluten sensitivity and inflammation to effectively target those patients with schizophrenia who will benefit most from this dietary intervention.
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
Overall the vast literature of peripheral biomarkers for major mental disorders is affected by bias and is underpowered, and no convincing evidence supported the existence of a trans-diagnostic biomarker.
Addressing the Gastrointestinal Health Associated With Schizophrenia: the Argument For A New Nutrition-based Intervention
The purpose of this paper is to review the literature linking schizophrenia with chronic inflammation and gluten sensitivity, and the need for dietary interventions that may improve multiple health outcomes for patients.
The brain-gut axis dysfunctions and hypersensitivity to food antigens in the etiopathogenesis of schizophrenia.
Research results seem to be very promising and indicate the possibility of improved clinical outcomes in some patients with schizophrenia by modifying diet, use of probiotics, and the implementation of antibiotic therapy of specific treatment groups, however, further research is needed on links between the intestinal microbiome and intestinal function as factors mediating the activation of the immune system.
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders
Combining biomarkers and large-scale use of “bottom-up” approaches to biomarker identification are likely to maximize the eventual clinical utility of antibody biomarkers in psychotic disorders.
Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophrenia
Gluten consumption has previously been implicated in the development of schizophrenia while an immunological link between gluten and schizophrenia was established by the detection of circulating


Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.
Celiac disease (CD) and schizophrenia have approximately the same prevalence, but epidemiologic data show higher prevalence of CD among schizophrenia patients. The reason for this higher
Markers of gluten sensitivity and celiac disease in bipolar disorder.
Evidence of increased levels of IgG antibodies to gliadin in the bipolar disorder population is found, however, such antibody increase is not accompanied by an elevation in IgA antibodies togliadin or the celiac disease-associated antibodies against deamidated Gliadin and tTG.
Novel immune response to gluten in individuals with schizophrenia
New understanding of gluten sensitivity
Patients complain of IBS-like symptoms and extraintestinal manifestations that occur shortly after the ingestion of gluten, and symptoms improve or disappear when gluten is withdrawn from the diet, and recur if gluten is reintroduced.
Elevated gliadin antibody levels in individuals with schizophrenia
  • O. Okusaga, R. Yolken, T. Postolache
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2013
This study confirmed an association between anti-gliadin IgG antibodies and schizophrenia, limited by its cross sectional design, which could lead to novel treatment targets, preventive and therapeutic considerations in schizophrenia.
Serological Tests in Gluten Sensitivity (Nonceliac Gluten Intolerance)
The serological pattern of GS is characterized by IgG AGA positivity in more than half of cases associated to IgA AGA in a few patients, but without EmA, tTGA, and DGP-AGA, which are the specific markers of celiac disease.
A study of circulating gliadin antibodies in schizophrenia among a Chinese population.
Quantitative analysis demonstrated that the mean levels of IgA antibodies against deamidated gliadin epitopes and TGM2 were significantly lower in patients with schizophrenia than the control subjects (P < .001 and P = .008, respectively).
Antibodies to wheat proteins in schizophrenia: relationship or coincidence?
Investigation of a larger group of patients, one with an increased permeability for gliadin and with a high antigliadin titre, and the other with a low permeability and having a low titre found that there are two groups of patients.